Aandeel VISTAPH6 VISTA PHARMACEUTICALS LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Vista Pharmaceuticals Limited

Aandelen

VISTAPH6

INE427C01021

Beurs gesloten - Bombay S.E.
Andere beurzen
 12:00:56 14-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
13,9 INR +0,36% Intraday-grafiek van Vista Pharmaceuticals Limited 0,00% -5,25%
28/05 Vista Pharmaceuticals Limited rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 maart 2024 CI
10/02 Vista Pharmaceuticals Limited rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Vista Pharmaceuticals Limited announced that it expects to receive INR 0.533334 million in funding
Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Vista Pharmaceuticals Limited Announces the Resignation of Mr. Nishant Talreja from the Post of Company Secretary, Compliance Officer and Key Managerial Personnel
Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Vista Pharmaceuticals Limited Announces Change in Corporate Office Address
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Vista Pharmaceuticals Limited announced that it has received INR 61.895 million in funding
Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Vista Pharmaceuticals Appoints Chairman
Vista Pharmaceuticals Limited Announces Executive Changes
Vista Pharmaceuticals Limited Approves Resignation of Narendra Gilaka as Independent Director of the Company
Vista Pharmaceuticals Limited announced that it expects to receive INR 66.895 million in funding
Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Vista Pharmaceuticals Limited Announces Resignation of Akash Bhagadia as Company Secretary and Compliance Officer
Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Vista Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers VISTAPH6
  4. Nieuws Vista Pharmaceuticals Limited
  5. Andere talen